2021
DOI: 10.1074/jbc.ra120.014190
|View full text |Cite
|
Sign up to set email alerts
|

The ATPase ATP6V1A facilitates rabies virus replication by promoting virion uncoating and interacting with the viral matrix protein

Abstract: Rabies virus (RABV) matrix protein (M) plays crucial roles in viral transcription, replication, assembly, and budding; however, its function during the early stage of virus replication remains unknown. Here, we mapped the protein interactome between RABV M and human host factors using a proteomic approach, finding a link to the V-type proton ATPase (V-ATPase) catalytic subunit A (ATP6V1A) which is located in the endosomes where RABV first enters. By downregulating or upregulating ATP6V1A expression in HEK293T … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 58 publications
0
16
0
Order By: Relevance
“…Analysis of this PIN demonstrated seven targeted signaling pathways, including WNT, MAPK/ERK, RAS, PI3K/AKT, toll-like receptor, JAK/STAT, and NOTCH, were involved in controlling cell cycle, cell survival, viral replication and folding, synapse regulation, and regulation of immunity. Phospholipase [25] , Binding inhibition assay [26] G RABV (CVS strain) NCAM Binding inhibition assay, Virus neutralization [27] G RABV (street strain) RABV (field strains, CVS strain & PV strain), EBLV-2 p75NTR Screening of the cDNA library, Co-IP [28] Reverse binding assay [29] G RABV (ERA strain, CVS-24 strain & street virus GX/09), WCBV mGluR2 RNAi strategy, Co-IP, Pull-down assay [35] G RABV (Virulent strains) MAST1,2 Yeast-two hybrid assay [108] G RABV (Attenuated strains) PTPN4 MAST2 DLG2 MPDZ Yeast-two hybrid assay [108] G RABV (CVS-11, SAD strains) SNAP25 Colocalization, Co-IP [37] N RABV (CVS strain) HSP70 1A,1B Immunoaffinity column immobilized with anti-N [39] N RABV (HEP-Flury strain) (CCTγ) Colocalization, RNAi strategy [42] N RABV (HEP-Flury strain) PFDN1 Colocalization [43] L RABV (SAD B19 strain) DLC1 Colocalization, Mutation in DLC1 motif [47] M RABV NEDD4 GST fusion proteins, Far-western blot assay [95] M RABV YAP1 Far-western blot assay [95] M RABV (PV strain) eIF3h Yeast-two hybrid assay, Surface plasmon resonance [92] M MOKV Cco1 Yeast-two hybrid assay, Co-IP, Colocalization [93] M RABV (Thailand, SAD B19, PV strains), MOKV, LBV, EBLV-1) RelAp43 Yeast-two hybrid assay, Co-IP [94] M RABV (a street strain) JAK1 Protein complementation assay [55] M RABV (a street strain) STAT1 Protein complementation assay [55] M RABV (ERA strain) ATP6V1A Co-IP, Pull-down assay [99] P RABV (CVS-11 strain), MOKV DLC1,2 Yeast-two hybrid assay [79] , Co-IP [78,79] , VirHostNet Database P, P3 isoform RABV (CVS strain) PML Co-IP, Colocalization [50] P RABV (SAD l16, CVS, SHBRV strains), MOKV, ABLV STAT1,2 Yeast-two hybrid assay [51] , Co-IP [51,104] ,VirHostNet database P RABV (CVs strain) STAT3 Co-IP, Colocalization…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Analysis of this PIN demonstrated seven targeted signaling pathways, including WNT, MAPK/ERK, RAS, PI3K/AKT, toll-like receptor, JAK/STAT, and NOTCH, were involved in controlling cell cycle, cell survival, viral replication and folding, synapse regulation, and regulation of immunity. Phospholipase [25] , Binding inhibition assay [26] G RABV (CVS strain) NCAM Binding inhibition assay, Virus neutralization [27] G RABV (street strain) RABV (field strains, CVS strain & PV strain), EBLV-2 p75NTR Screening of the cDNA library, Co-IP [28] Reverse binding assay [29] G RABV (ERA strain, CVS-24 strain & street virus GX/09), WCBV mGluR2 RNAi strategy, Co-IP, Pull-down assay [35] G RABV (Virulent strains) MAST1,2 Yeast-two hybrid assay [108] G RABV (Attenuated strains) PTPN4 MAST2 DLG2 MPDZ Yeast-two hybrid assay [108] G RABV (CVS-11, SAD strains) SNAP25 Colocalization, Co-IP [37] N RABV (CVS strain) HSP70 1A,1B Immunoaffinity column immobilized with anti-N [39] N RABV (HEP-Flury strain) (CCTγ) Colocalization, RNAi strategy [42] N RABV (HEP-Flury strain) PFDN1 Colocalization [43] L RABV (SAD B19 strain) DLC1 Colocalization, Mutation in DLC1 motif [47] M RABV NEDD4 GST fusion proteins, Far-western blot assay [95] M RABV YAP1 Far-western blot assay [95] M RABV (PV strain) eIF3h Yeast-two hybrid assay, Surface plasmon resonance [92] M MOKV Cco1 Yeast-two hybrid assay, Co-IP, Colocalization [93] M RABV (Thailand, SAD B19, PV strains), MOKV, LBV, EBLV-1) RelAp43 Yeast-two hybrid assay, Co-IP [94] M RABV (a street strain) JAK1 Protein complementation assay [55] M RABV (a street strain) STAT1 Protein complementation assay [55] M RABV (ERA strain) ATP6V1A Co-IP, Pull-down assay [99] P RABV (CVS-11 strain), MOKV DLC1,2 Yeast-two hybrid assay [79] , Co-IP [78,79] , VirHostNet Database P, P3 isoform RABV (CVS strain) PML Co-IP, Colocalization [50] P RABV (SAD l16, CVS, SHBRV strains), MOKV, ABLV STAT1,2 Yeast-two hybrid assay [51] , Co-IP [51,104] ,VirHostNet database P RABV (CVs strain) STAT3 Co-IP, Colocalization…”
Section: Discussionmentioning
confidence: 99%
“…They also suggested that M-STAT1 interaction induces the cytoplasmic retention of STAT1, therefore, enhances the capacity of RABV P to bind STAT1 and interferes with the downstream events in the pathway [ 55 ] . Just recently, a new function for M has been discovered in virion uncoating via binding to V-ATPase catalytic subunit A (ATP6V1A) [ 99 ] . V-ATPase complex is involved in endosomal acidification by pumping H + from the cell cytoplasm into the lumen.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Rabies is an important zoonotic infectious disease caused by rabies virus (RABV), with a mortality rate of almost 100% [ 1 ]. Neurotropic RABV causes fatal encephalomyelitis after infection of the central nervous system, and approximately 60,000 people die from rabies worldwide each year, with more than 15 million people receiving post-exposure prophylaxis [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%